Trexquant Investment’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-12,483	Closed	-$107K	–	1070
2018 Q3	$107K	Buy	+12,483	New	+$107K	0.01%	892
2018 Q1	–	Sell	-17,971	Closed	-$186K	–	1120
2017 Q4	$186K	Buy	+17,971	New	+$186K	0.02%	954